Mazzei, Amelia
Ingabire, Rosine
Karita, Etienne
Mukamuyango, Jeannine
Nyombayire, Julien
Parker, Rachel
Tichacek, Amanda
Allen, Susan
Wall, Kristin M.
Funding for this research was provided by:
Centers for Disease Control and Prevention (U2GPS001839, U2GPS 1904)
National Institutes of Health (R01 AI23980, R01 AI40951, R01 MH66767, R01 MH95503, R01 HD40125, R01 HD072659, 5D43TW001042, P30 AI050409)
International AIDS Vaccine Initiative (SOW2166)
Article History
Received: 7 July 2021
Accepted: 12 November 2021
First Online: 15 December 2021
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. Prior to implementation of the program evaluation project in June of 2016, this program evaluation was approved by the Rwandan National Ethics Committee. Prior to implementation of the project in June of 2016, this program evaluation was determined to be non-human subjects research by the Emory Institutional Review Board criteria. The Rwandan National Ethics Committee and granted a waiver of informed consent. Programmatic data were de-identified by government clinic staff before sharing with PSF investigators.
: Not applicable.
: The authors report no conflict of interest.